Skip to content

Science & Health

Research, biology, medicine, public health, and discovery.

BIOLOGY AND BIOTECHNOLOGY
ADXN Announces Q3 2026 Financial Results Call - ADXN
Addex Therapeutics will report its Q3 2026 financial results on November 25. CEO Tim Dyer will provide a business update during the call.
SWITZERLANDDIPRAGLURANTADXN
4 articles